Key Highlights
● Surgery Partners surged on November 9 after HealthSpan raised its offer.
● HealthSpan lifted its bid to $25 per share.
● A rival offer of $28 per share had emerged.
● Shares were up by a double-digit amount at 1:07 p.m. Eastern time.
The bidding war escalates
Surgery Partners (NASDAQ:SGRY) surged on Monday, November 9, 2026, after HealthSpan raised its cash offer for the outpatient surgery company. According to news reports, HealthSpan lifted its bid to $25 per share after a rival offer of $28 per share emerged. Market data described the deal as valued at up to $6 billion. Surgery Partners' board backs the HealthSpan deal, reports said.
The shares were up by a double-digit amount at 1:07 p.m. Eastern time, according to market coverage.
Reading the numbers
At first glance, a board supporting a $25 offer while a $28 bid is on the table looks unusual. The reports did not explain the reasoning. In Takeover contests, boards weigh more than the headline price, including how a deal is financed, what conditions are attached, how likely it is to close and how long it might take. Structure can vary significantly between bids, so the per-share figures alone may not capture every difference.
What investors could see clearly was that competition for the company was intensifying. When more than one bidder is interested, shareholders often stand to benefit, and the market tends to price in the possibility of further improvement.
What Surgery Partners does
Surgery Partners operates surgical facilities, including ambulatory surgery centers and surgical hospitals, across the United States. These facilities handle procedures such as orthopedic, ophthalmology and gastrointestinal surgeries that do not require a traditional overnight hospital stay.
The shift of procedures from hospitals to outpatient settings has been a long-running trend in US health care, driven by lower costs and patient convenience. That trend helps explain why operators like Surgery Partners attract interest from buyers.
A day rich in deals
Surgery Partners was one of several companies moving on transaction news. DoubleDown Interactive (NASDAQ:DDI) jumped after majority owner DoubleU Games offered $16.25 per ADS for the shares it does not own. Greenfire Resources soared after agreeing to be acquired by Strathcona Resources, and Charles River Laboratories (NYSE:CRL) agreed to buy Frontage's bioanalysis Business for about $470 million, according to market reports.
The broader market provided a supportive backdrop. The Nasdaq Composite gained 673.71 points to 25,253.14, its best session since July 30, and the S&P 500 rose 173.08 points to 7,549.94. All 11 S&P 500 sectors rose, as a slide in oil prices on hopes for a US-Iran peace deal eased Inflation worries and chip stocks rebounded.
The financing backdrop
Large takeovers often depend at least partly on borrowing, which makes interest rates relevant to how bidders value a target and how much they can afford to offer. The 10-year Treasury Yield held near 4.87, according to market data, well below its October peak. Traders, however, saw a Federal Reserve rate hike in December as likely, according to Futures Market pricing. Higher borrowing costs can affect how much bidders are willing to pay.
Board Response to Rival Bid
The next moves in the contest are the main focus. Investors will watch whether the rival bidder responds, whether HealthSpan improves its terms again and how Surgery Partners' board explains its recommendation in formal filings. Details on financing, conditions and timing will help clarify the gap between the two headline prices.
Shareholder and regulatory approvals will also be key steps. Meanwhile, Tuesday's October consumer price index, the last before the Fed's December 8-9 meeting, could influence rate expectations and the cost of financing large deals.






Please wait processing your request...